James A. Walker

1.6k total citations
52 papers, 1.1k citations indexed

About

James A. Walker is a scholar working on Molecular Biology, Cell Biology and Neurology. According to data from OpenAlex, James A. Walker has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Cell Biology and 15 papers in Neurology. Recurrent topics in James A. Walker's work include Neurofibromatosis and Schwannoma Cases (14 papers), Hippo pathway signaling and YAP/TAZ (9 papers) and Neurobiology and Insect Physiology Research (5 papers). James A. Walker is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (14 papers), Hippo pathway signaling and YAP/TAZ (9 papers) and Neurobiology and Insect Physiology Research (5 papers). James A. Walker collaborates with scholars based in United States, United Kingdom and France. James A. Walker's co-authors include Nicola S. Russell, Toby O. Smith, Nicholas J. Dyson, Meena Upadhyaya, Wayne Miles, André Bernards, James F. Gusella, Jean Y. Gouzi, Ruth H. Palmer and Anthi A. Apostolopoulou and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

James A. Walker

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Walker United States 20 437 232 214 167 141 52 1.1k
Valeria Parente Italy 16 1.0k 2.4× 97 0.4× 85 0.4× 117 0.7× 44 0.3× 25 1.4k
Francesca Ferrari Italy 17 323 0.7× 87 0.4× 152 0.7× 31 0.2× 145 1.0× 41 1.1k
Francesca E. Mackenzie United Kingdom 12 630 1.4× 84 0.4× 650 3.0× 104 0.6× 31 0.2× 14 1.5k
Daniel Andersson Sweden 20 578 1.3× 40 0.2× 142 0.7× 88 0.5× 244 1.7× 43 1.4k
Seiichi Kawamata Japan 20 277 0.6× 34 0.1× 131 0.6× 77 0.5× 95 0.7× 65 989
Chiara Rinaldi Italy 13 1.0k 2.3× 58 0.3× 76 0.4× 82 0.5× 54 0.4× 24 1.3k
Maria J. Crowe United States 12 318 0.7× 273 1.2× 465 2.2× 86 0.5× 19 0.1× 15 1.5k
Ruth Williams United Kingdom 20 544 1.2× 62 0.3× 110 0.5× 542 3.2× 38 0.3× 48 1.7k
Kyoko Koishi New Zealand 21 1.0k 2.4× 94 0.4× 251 1.2× 144 0.9× 19 0.1× 35 1.5k
Andrei B. Borisov United States 25 1.2k 2.8× 52 0.2× 360 1.7× 196 1.2× 30 0.2× 39 1.7k

Countries citing papers authored by James A. Walker

Since Specialization
Citations

This map shows the geographic impact of James A. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Walker more than expected).

Fields of papers citing papers by James A. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Walker. The network helps show where James A. Walker may publish in the future.

Co-authorship network of co-authors of James A. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Walker. A scholar is included among the top collaborators of James A. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Walker. James A. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutmann, David H., Corina Anastasaki, Aditi Gupta, et al.. (2025). Cognition and behavior in neurofibromatosis type 1: report and perspective from the Cognition and Behavior in NF1 (CABIN) Task Force. Genes & Development. 39(9-10). 541–554. 1 indexed citations
2.
Lim, Bora, Stephanie J. Bouley, James A. Walker, et al.. (2025). Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Cancers. 17(11). 1852–1852. 1 indexed citations
4.
Khan, Eshan, Stephanie J. Bouley, Jalal Siddiqui, et al.. (2025). Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled Growth. Thyroid. 35(2). 177–187. 2 indexed citations
5.
Bouley, Stephanie J., Andrew V. Grassetti, Robert J. Allaway, et al.. (2024). Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of Cell Science. 137(15). 2 indexed citations
6.
Stevens, Megan, Yuanli Wang, Stephanie J. Bouley, et al.. (2024). Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. Molecular Oncology. 19(3). 825–851. 3 indexed citations
7.
Durkin, Jaclyn, et al.. (2023). Neurofibromin 1 regulates early developmental sleep in Drosophila. SHILAP Revista de lepidopterología. 15. 100101–100101. 2 indexed citations
8.
Khan, Eshan, Misbah Khan, Jalal Siddiqui, et al.. (2022). PUMILIO competes with AUF1 to control DICER1 RNA levels and miRNA processing. Nucleic Acids Research. 50(12). 7048–7066. 5 indexed citations
9.
Brown, Elizabeth, Tamara Boto, Scarlet J. Park, et al.. (2021). Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. Nature Communications. 12(1). 4285–4285. 19 indexed citations
10.
Busto, Germain U., Ana Boulanger, Edward Giniger, et al.. (2021). Htt is a repressor of Abl activity required for APP-induced axonal growth. PLoS Genetics. 17(1). e1009287–e1009287. 10 indexed citations
11.
King, Lanikea B., et al.. (2020). Developmental loss of neurofibromin across distributed neuronal circuits drives excessive grooming in Drosophila. PLoS Genetics. 16(7). e1008920–e1008920. 15 indexed citations
12.
Amo, Víctor López Del, Kurt J. Cox, Shubhroz Gill, et al.. (2020). Small-Molecule Control of Super-Mendelian Inheritance in Gene Drives. Cell Reports. 31(13). 107841–107841. 31 indexed citations
13.
Moscato, Emilia H., Christine Dubowy, James A. Walker, & Matthew S. Kayser. (2020). Social Behavioral Deficits with Loss of Neurofibromin Emerge from Peripheral Chemosensory Neuron Dysfunction. Cell Reports. 32(1). 107856–107856. 13 indexed citations
14.
Jordan, Justin T., Miriam J. Smith, James A. Walker, et al.. (2018). LZTR1 mutations associated with greater pain among patients with schwannomatosis (P6.142). Neurology. 90(15_supplement). 1 indexed citations
15.
Perea, Daniel, Jordi Guiu, Bruno Hudry, et al.. (2017). Ret receptor tyrosine kinase sustains proliferation and tissue maturation in intestinal epithelia. The EMBO Journal. 36(20). 3029–3045. 25 indexed citations
16.
Hutchinson, Claire V., James A. Walker, & Colin Davidson. (2014). Oestrogen, ocular function and low-level vision: a review. Journal of Endocrinology. 223(2). R9–R18. 31 indexed citations
17.
Smith, Miriam J., Sonia Esparza, Vanessa L. Merker, et al.. (2012). Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis. Clinical Biochemistry. 46(7-8). 698–700. 3 indexed citations
18.
Gouzi, Jean Y., James A. Walker, Anthi A. Apostolopoulou, et al.. (2011). The Receptor Tyrosine Kinase Alk Controls Neurofibromin Functions in Drosophila Growth and Learning. PLoS Genetics. 7(9). e1002281–e1002281. 74 indexed citations
19.
Hálfdánarson, Þorvarður R., James A. Walker, Mark R. Litzow, & Curtis A. Hanson. (2008). Severe vitamin B12 deficiency resulting in pancytopenia, splenomegaly and leukoerythroblastosis. European Journal Of Haematology. 80(5). 448–451. 16 indexed citations
20.
Chi, Yiqing, Mary E. Zeigler, James A. Walker, et al.. (1998). Elaboration of Matrix Metalloproteinase Inhibitors by Human Skin in Organ Culture and by Skin Cells in Monolayer Culture: Relationship to Invasion. PubMed. 18(1). 27–34. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026